“I-140 approvals feel like the light at the end of the tunnel during this most difficult time. Thank you. Thank you. Thank you.”
On February 25th, 2021 and June 1st, 2021, we received another EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver) approval for a Research Associate in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Associate
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
“Therefore, a better understanding of how to identify and effectively treat cancer at its point of origin has significant implications for the more than 1.8 million Americans diagnosed with the disease annually. It is clear that his studies directly address a major health issue and are beneficial to the United States as a whole.”
“This is of obvious value to the United States given that approximately 1 in 3 Americans will develop cancer throughout their lifetime. His studies ensure more effective treatment for those afflicted and lay the groundwork for further research in the field. Based on his substantial achievements and the importance of his studies to both his peers and to Americans as a whole, it is clear his work must be supported by the United States.”
The aforementioned 2 statements have been extracted from 2 of the 5 recommendation letters submitted by our client acquired from well-known researchers in the field of biomedical science.
Our client, a research associate holding a Ph.D. in biophysics, approached North America Immigration Law Group as he was certain that our law firm would definitely support him to achieve his NIW (National Interest Waiver) petition approval. As per our services, we advised our client to submit more evidence along with letters of support to further this case. Accordingly, after reviewing his credentials, undoubtedly, we were impressed and agreed to take his case forward to USCIS for further adjudication.
After we filed our client’s I-140 NIW petition, he retained our services to get one more petition filed under the I-140 EB1A (Alien of Extraordinary Ability) visa category. Since we had already worked on his NIW case, we affirmed articulating another petition on his behalf without any hesitance. We laid out unique structures in the respective cases and mentioned the following:
- One of the foremost aspects we noted was his research on the role of receptor localization in human development and drug delivery and how it was crucial addressing some of the world’s most pressing issues, including cancer treatment, confirming that his research is relevant to improving drug delivery methods, therefore not only reducing the burden of cancer but also accelerating the production of drugs for cancer and other diseases, thereby benefiting the global pharmaceutical industry.
- Moreover, we discussed the 126 citations accumulated from 5 peer-reviewed journal articles (3 first-authored) he published in some of the field’s leading publications, which are recognized for their high standards and wide international readership. There, his recurrent inclusion in such titles is a testament to his research’s saliency and high value. Ultimately, the approval of his research by the editors of these eminent journals is invaluable proof that he should be sponsored in the continuation of his research here in the United States. In addition, many other researchers have cited his study due to its value and practical research applications from at least 17 countries, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.
- Besides, we observed his excellence as a researcher in his repeated invitation by some of the leading publications in the field to conduct peer reviews and review manuscripts for publication. We specified that he has conducted 3 reviews, which is a distinct honor as the peer-review process is an integral factor of scientific publication that assists journal editors in maintaining the strict requirements and reputation of their periodicals. Overall, he has lent his knowledge and skills to many reviews, assisting in assuring the quality of articles published by several reputable journals.
- Finally, we showcased that his research has also garnered the attention of major federal funding bodies. His work in this regard has received support from the National Science Foundation and the National Institutes of Health, indicating the immense value of his findings to issues of national importance. These are major funding bodies in the United States with a vested interest in work that addresses fundamental issues in medicine and scientific progress which further underscores the impact of our client’s research on the global scientific community within the United States.
Overall, we are super excited that our client allowed us to manage both of his I-140 petitions and be a part of this success story since he obtained his I-140 NIW and EB1A petitions approval 4 months apart. We are glad that once again our team’s efforts and diligence in both of our client’s cases paid off well. We would like to congratulate him as he advances in his chosen field, we also, sincerely thank him for associating with us not only for his I-140 petitions but for retaining our law firm for his I-485 applications as well.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Free evaluation email: firstname.lastname@example.org
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to: